Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.14.6135

Differential Diagnosis of Malignant Biliary Tract Cancer from Benign Tissues using Apparent Diffusion Coefficient Measurements with Diffusion Weighted Imaging in Asians  

Zhao, Xu-Ya (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
Zhou, Shi (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
Wang, Da-Zhi (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
He, Wei (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
Li, Jun-Xiang (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
Zhang, Shuai (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.14, 2015 , pp. 6135-6140 More about this Journal
Abstract
Background: The aim of this meta-analysis was to assess the efficacy of the apparent diffusion coefficient (ADC) value of diffusion-weighted MRI (DWI) for differentiating biliary tract cancer (BTC) from benign biliary tract diseases in Asians. Materials and Methods: We systematically searched Embase and PubMed prior to December 2014. Eight studies conducted in Asians met our predetermined inclusion criteria. Results: Our meta-analysis results showed that ADC values in BTC tissues were significantly lower than in benign biliary tract tissues (SMD = -1.54, 95%CI: -1.75~-1.33, P<0.001). Subgroup analysis based on the MRI machine type showed that the ADC values were consistent, accurate and reliable in the diagnosis of BTC when comparing cancer tissue vs. benign tissue under the Siemens 1.5 T/3.0 T, Philips 1.5 T/3.0 T, GE 1.5 T, and Toshiba 1.5 T types, respectively (all P<0.05). Further, ADC values were still consistent and accurate in the differential diagnosis of BTC under the b value of 800 and $1000s/mm^2$ (all P<0.05). Conclusions: Our findings supported potential clinical applications of DWI ADC values in differentiating BTC from benign biliary tract diseases in Asians.
Keywords
Biliary tract cancer; diffusion-weighted magnetic resonance imaging; meta-analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Khoo MM, Tyler PA, Saifuddin A, et al (2011). Diffusionweighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol, 40, 665-81.   DOI
2 Kim JH, Byun JH, Lee SJ, et al (2012). Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography. Eur Radiol, 22, 2502-13.   DOI
3 Kim SJ, Lee JM, Kim H, et al (2013a). Role of diffusionweighted magnetic resonance imaging in the diagnosis of gallbladder cancer. J Magn Reson Imag, 38, 127-37.   DOI
4 Kim SJ, Lee JM, Kim H, et al (2013b). Role of diffusionweighted magnetic resonance imaging in the diagnosis of gallbladder cancer. J Magn Reson Imag, 38, 127-37.   DOI
5 Kyriazi S, Collins DJ, Morgan VA, et al (2010). Diffusionweighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics, 30, 1269-85.   DOI
6 Lambrecht M, Van Calster B, Vandecaveye V, et al (2014). Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol, 110, 429-34.   DOI
7 Le Bihan D (2013). Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiol, 268, 318-22.   DOI
8 Lee NK, Kim S, Kim GH, et al (2012). Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging. World J Gastroenterol, 18, 4102-17.   DOI
9 Lee NK, Kim S, Kim TU, et al (2014a). Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder. Clin Radiol, 69, 78-85.   DOI
10 Akay S, Kocaoglu M, Emer O, et al (2013). Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol, 57, 274-82.   DOI
11 Attariwala R, Picker W (2013). Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging, 38, 253-68.   DOI
12 Baheti AD, Tirumani SH, Rosenthal MH, et al (2014). Diagnosis and management of intrahepatic cholangiocarcinoma: a comprehensive update for the radiologist. Clin Radiol, 69, 463-70.   DOI
13 Castro FA, Koshiol J, Hsing AW, et al (2013). Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer, 133, 1664-71.   DOI
14 Charatcharoenwitthaya P, Enders FB, Halling KC, et al (2008). Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatol, 48, 1106-17.   DOI
15 Chen H, Manning AK, Dupuis J (2012). A method of moments estimator for random effect multivariate meta-analysis. Biometrics, 68, 1278-84.   DOI
16 Malayeri AA, El Khouli RH, Zaheer A, et al (2011). Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics, 31, 1773-91.   DOI
17 Lee NK, Kim S, Kim TU, et al (2014b). Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder. Clin Radiol, 69, 78-85.   DOI
18 Li B, Li Q, Nie W, et al (2014). Diagnostic value of wholebody diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a metaanalysis. Eur J Radiol, 83, 338-44.   DOI
19 Low RN, Sebrechts CP, Barone RM, et al (2009). Diffusionweighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol, 193, 461-70.   DOI
20 Morizane C, Okusaka T, Mizusawa J, et al (2013). Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). Cancer Sci, 104, 1211-6.   DOI
21 Ogawa T, Horaguchi J, Fujita N, et al (2012). High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: Differentiation between benignity and malignancy. J Gastroenterol, 47, 1352-60.   DOI
22 Onur MR, Ozturk F, Aygun C, et al (2012). Role of the apparent diffusion coefficient in the differential diagnosis of gastric wall thickening. J Magn Reson Imaging, 36, 672-7.   DOI
23 Padhani AR, Liu G, Koh DM, et al (2009). Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia, 11, 102-25.   DOI
24 Randi G, Malvezzi M, Levi F, et al (2009). Epidemiology of biliary tract cancers: an update. Ann Oncol, 20, 146-59.
25 Park HJ, Kim SH, Jang KM, et al (2014). The role of diffusionweighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol, 24, 947-58.   DOI
26 Peters JL, Sutton AJ, Jones DR, et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80.   DOI
27 Queiroz MA, Hullner M, Kuhn F, et al (2014). Use of diffusionweighted imaging (DWI) in PET/MRI for head and neck cancer evaluation. Eur J Nucl Med Mol Imaging, 41, 2212-21.   DOI
28 Shin HR, Oh JK, Masuyer E, et al (2010). Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev, 11, 1159-66.
29 Solak A, Solak I, Genc B, et al (2013). The role of diffusionweighted examination in non-polyploid gallbladder malignancies: A preliminary study. Turkish J Gastroenterol, 24, 148-53.   DOI
30 Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, et al (2012). Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score
31 Sterne JA, Egger M (2001). Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol, 54, 1046-55.   DOI
32 Sugita R, Yamazaki T, Furuta A, et al (2009a). High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: Preliminary study and results. Eur Radiol, 19, 1794-8.   DOI
33 Gourgiotis S, Kocher HM, Solaini L, et al (2008). Gallbladder cancer. Am J Surg, 196, 252-64.   DOI
34 Chen LD, Xu HX, Xie XY, et al (2008). Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol, 81, 881-9.   DOI
35 Donati OF, Chong D, Nanz D, et al (2014). Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiol, 270, 454-63.   DOI
36 Furuse J, Kasuga A, Takasu A, et al (2012). Role of chemotherapy in treatments for biliary tract cancer. J Hepatobiliary Pancreat Sci, 19, 337-41.   DOI
37 Heijmen L, Verstappen MC, Ter Voert EE, et al (2012). Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use? Crit Rev Oncol Hematol, 83, 194-207.   DOI
38 Hsing AW, Sakoda LC, Rashid A, et al (2008). Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res, 68, 6442-52.   DOI
39 Irie H, Kamochi N, Nojiri J, et al (2011). High b-value diffusionweighted MRI in differentiation between benign and malignant polypoid gallbladder lesions. Acta radiologica (Stockholm, Sweden : 1987), 52, 236-40.   DOI
40 Jang KM, Kim SH, Lee SJ, et al (2013). Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma. Radiol, 266, 491-501.   DOI
41 Kang TW, Kim SH, Park HJ, et al (2013). Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: Added value of diffusionweighted MRI. Clinical Radiol, 68, 992-1001.   DOI
42 Wen H, Yoo SS, Kang J, et al (2010). A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol, 52, 228-33.   DOI
43 Sugita R, Yamazaki T, Furuta A, et al (2009b). High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results. Eur Radiol, 19, 1794-8.   DOI
44 Tan CH, Lim KS (2013). MRI of gallbladder cancer. Diagn Interv Radiol, 19, 312-9.
45 Vilana R, Forner A, Bianchi L, et al (2010). Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatol, 51, 2020-9.   DOI
46 Whiting PF, Weswood ME, Rutjes AW, et al (2006). Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 6, 9.   DOI   ScienceOn
47 Wu LM, Xu JR, Lu Q, et al (2013). A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Gastroenterol Hepatol, 28, 227-34.   DOI   ScienceOn
48 Yoshioka M, Watanabe G, Uchinami H, et al (2013). Diffusionweighted MRI for differential diagnosis in gallbladder lesions with special reference to ADC cut-off values. Hepato-Gastroenterol, 60, 692-8.